Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
Status:
Recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
In this study, the Investigators plan to determine the optimal means to prevent or slow the
progression of kidney disease among genetically at-risk northern Nigerian HIV-infected
adults. Based on data from studies of diabetic kidney disease that used medications that
block the renin angiotensin aldosterone system (RAAS), we plan to evaluate whether or not
RAAS inhibition (using a widely available medication that blocks RAAS) in HIV-infected adults
produces similarly promising results.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University Medical Center
Collaborators:
Aminu Kano Teaching Hospital National Cancer Institute (NCI) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) SAIC-Frederick, Inc.